Today: 20 May 2026
NVIDIA’s Stock Soars to New Highs – Analysts Eye Further Gains

NVIDIA (NVDA) Today — Nov. 6, 2025: Huang clarifies China AI-race remarks; U.K. honor crowns AI leadership; VAST Data–CoreWeave inks $1.17B deal; NVDA trades near $195 ahead of Nov. 19 earnings

Top headlines at a glance

  • Huang’s China comments — and clarification. After reports that CEO Jensen Huang said “China is going to win the AI race,” Nvidia pointed to his follow-up post saying China is “nanoseconds behind America” and urged the U.S. to “race ahead” by winning developers worldwide. Reuters also notes his remarks came amid ongoing U.S. export limits and recent political statements about restricting top-end GPUs. Reuters
  • Prestige U.K. honors for Nvidia leadership. Jensen Huang and Chief Scientist Bill Dally were named laureates of the 2025 Queen Elizabeth Prize for Engineering for foundational work in accelerated computing; Huang also received the Professor Stephen Hawking Fellowship at the Cambridge Union during a week of AI-focused events in London.
  • Ecosystem deal of the day.VAST Data signed a $1.17 billion multi‑year agreement with CoreWeave to serve as the neocloud’s primary data platform—another sign of heavy build‑out around Nvidia-powered AI infrastructure. (Both firms have deep ties to Nvidia’s ecosystem and investors.)

What changed today — and why it matters

1) Huang’s China remarks move from sound bite to strategy

Reuters reports that Huang’s “China will win” comment—made on the sidelines of the FT Future of AI Summit—was followed hours later by a clarification on X emphasizing that America can win by accelerating innovation and courting global developers, including those in China. He reiterated that policy should avoid ceding half the world’s AI developer base. The report also notes U.S. export controls remain a flashpoint; Nvidia hasn’t sought China licenses, and recent comments by the U.S. president about reserving top Blackwell chips for domestic customers underscore the policy uncertainty surrounding Nvidia’s fastest GPUs. Takeaway: today’s messaging tries to align geopolitics with Nvidia’s developer‑first strategy while sidestepping direct sales into China. Reuters

2) International recognition bolsters Nvidia’s “national infrastructure” narrative

This afternoon, Nvidia’s blog confirmed Huang and Dally received the 2025 Queen Elizabeth Prize for Engineering for accelerated computing—technology that underpins modern AI. The QEPrize site lists both leaders among seven laureates, and U.K. outlets reported the King discussed AI risks with honorees during the ceremony. Why investors care: awards aren’t revenue, but they reinforce Nvidia’s position at the core of AI’s hardware+software stack and support its global government and academia relationships that often precede datacenter and research deployments.

3) The build‑out keeps building: VAST Data–CoreWeave $1.17B pact

Reuters’ exclusive says AI storage/software vendor VAST Data and neocloud CoreWeave deepened their partnership via a $1.17B contract, aligning product roadmaps to move training data faster to GPU clusters. VAST previously disclosed $200M ARR and positive FCF; Reuters has reported Nvidia and CapitalG discussed participating in its next raise—context for why a large, long‑dated contract matters. Why this touches NVDA: CoreWeave’s growth is tightly coupled to Nvidia GPU capacity; deals that improve GPU utilization (I/O, storage, data management) help keep Nvidia systems “sweating” and can pull forward demand for more accelerators and networking. Reuters+1


Market context

  • AI-levered equities wobble, but NVDA stays a bellwether. Reuters flagged renewed volatility in AI‑linked names this week; that macro backdrop, plus headline risk around export policy, is keeping day‑to‑day swings elevated.
  • Policy watch — UAE export licenses (this week’s context). Earlier this week, the U.S. cleared Microsoft to ship tens of thousands of Nvidia GB300‑class chips to the UAE under strict safeguards, part of a multi‑year infrastructure investment. While not today’s news, it frames the policy reality behind Huang’s developer‑access argument.

NVDA: levels and catalysts to watch

  • Price & range: As of ~13:36 UTC, NVDA was trading around $195. Recent 52‑week range has spanned roughly $86.6–$212.2, per Reuters. Short‑term flows remain sensitive to AI‑macro headlines and Blackwell shipment chatter.
  • Earnings date set: Nvidia will report Q3 FY2026 results on Wednesday, Nov. 19 at 2:00 p.m. PT (with CFO commentary posted before the call). Expect updates on Blackwell/GB300 ramps, supply, and demand visibility into 2026.

Analyst takeaway (editorial)

  • Narrative today: Nvidia is simultaneously a technology standard, a geopolitical focal point, and a cultural symbol of the AI age. Today’s UK honors amplify the first; Huang’s clarification tries to calm the third; and the VAST–CoreWeave deal shows the second—AI infrastructure build‑out—continues, regardless of market jitters.
  • What would move the stock next: concrete data on Blackwell yields/shipments, networking availability, and gross‑margin cadence; evidence of new sovereign/DOE‑scale wins; and any change to U.S. export posture that affects non‑China markets (e.g., the UAE green‑light).

Sources & timestamps (Nov. 6, 2025 unless noted)

  • Reuters recap of Huang’s remarks and clarification; export‑policy backdrop.
  • Nvidia blog confirming QEPrize and Hawking Fellowship; event details.
  • QEPrize official site listing 2025 laureates.
  • PA Media/Yahoo Finance UK on the King’s AI discussions at the ceremony.
  • Reuters exclusive: VAST Data–CoreWeave $1.17B agreement.
  • Reuters: AI‑stock volatility context this week.
  • Reuters/AP (this week): U.S. license enabling Microsoft to ship Nvidia GB300‑class chips to UAE.
  • Nvidia Investor Relations: Q3 FY26 earnings call on Nov. 19.

Disclosure: This article is for information and news purposes only and is not investment advice.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
NYSE Skyrockets to Record Highs as AI Frenzy, Fed Rate Cut Bets Fuel Stock Surge
Previous Story

Stocks to Sell Today (Nov 6, 2025): e.l.f. Beauty, Duolingo, DoorDash, Super Micro, Meta, Palantir—and Airline Majors Under FAA Cuts

Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts
Next Story

Tesla (TSLA) Today: Shareholders Vote on Musk’s Record Pay, Cybertruck Lineup Shifts—What It Means for the Stock (Nov. 6, 2025)

Go toTop